Results 141 to 150 of about 18,888 (207)

Rituximab in primary podocytopathies: efficacy and safety in a retrospective cohort. [PDF]

J Bras Nefrol
Sales GTM, Fernandes DE, Kirsztajn GM.
europepmc   +1 more source

[New concepts in the physiopathology of hypertension. Purinergic receptors]. [PDF]

Arch Cardiol Mex
Bautista-Pérez R, Pérez-Méndez Ó, Franco M.   +2 more
europepmc   +1 more source

IgA nephropathy in children: how much can we trust prognostic tools? [PDF]

J Bras Nefrol
Penido MGMG, Bresolin NL, Ferra-Neto O.
europepmc   +1 more source

[Impact of obesity and diabetes on health and cardiovascular disease]. [PDF]

Aten Primaria
Lecube A.
europepmc   +1 more source

Inhibidores del sistema renina-angiotensina en pacientes con COVID-19

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2020
Sandra Martínez Pizarro
doaj  

[Clinical characteristics and pharmacological treatment of patients with heart failure in a primary health care cohort]. [PDF]

Aten Primaria
Giner-Soriano M, Monfà R, Vives R, Fernández-García S, Vallano A, Morros R.   +5 more
europepmc   +1 more source

Hipertensión e hiperaldosteronismo en una gata con adenocarcinoma adrenal [PDF]

, 2008
Torrent, E.
core  

Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective. [PDF]

J Bras Nefrol
Rico-Fontalvo J, Reina M, Soler MJ, Unigarro-Palacios M, Castañeda-González JP, Quintero JJ, Raad-Sarabia M, Moraes TP, Daza-Arnedo R.   +8 more
europepmc   +1 more source